Novel treatment options for ulcerative colitis

Author： Vaughn Byron P   Moss Alan C  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.11, 2013-11, pp. : 1057-1069

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 4, 2015-04 ,pp. : 412-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 979-979

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 551-555

John Wiley & Sons Inc

Access to resources Recommend Favorite

Case of psoriasis vulgaris developing ulcerative colitis during adalimumab treatment

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 10, 2015-10 ,pp. : 1029-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite

Case of psoriasis vulgaris developing ulcerative colitis during adalimumab treatment

By  

THE JOURNAL OF DERMATOLOGY, Vol. 385-2407, Iss. 10, 2015-10 ,pp. : 1029-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite